Labaton Sucharow, a nationally ranked and award-winning shareholder rights law firm, announces that it is investigating potential violations of the federal securities laws by Natera Inc. (NASDAQ:NTRA).

On March 9, 2022, before the market opened, Hindenburg Research issued a short report alleging that "Natera's revenue growth has been fueled by deceptive sales and billing practices aimed at doctors, insurance companies and expectant mothers." The report includes other potential issues at the prenatal testing company.

Shares of Natera, Inc. stock dropped more than 15% in premarket trading on March 9, 2022.

If you currently own stock or options in Natera Inc. and suffered a loss, click here to participate.

If you want to receive additional information and protect your investments free of charge, please contact David J. Schwartz using the toll-free number (800) 321-0476 or via email at david@labaton.com.

About the Firm

Labaton Sucharow LLP is one of the world's leading complex litigation firms representing clients in securities, corporate governance and shareholder rights, consumer, and cybersecurity and data privacy litigation, as well as whistleblower representation. Labaton Sucharow has been recognized for its excellence by the courts and peers, and it is consistently ranked in leading industry publications. Offices are located in New York, NY, Wilmington, DE, and Washington, D.C. More information about Labaton Sucharow is available at labaton.com.

View source version on businesswire.com: https://www.businesswire.com/news/home/20220316005727/en/